Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 2
2013 2
2014 3
2015 3
2016 2
2020 2
2021 1
2022 2
2023 1
2024 2
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Pre-existing infiltration with T cells and CD14+ myeloid cells is associated with treatment response to imiquimod in primary and recurrent vulvar high-grade squamous intraepithelial lesions.
Muntinga CLP, de Vos van Steenwijk PJ, Kooreman LFS, Regauer S, Abdulrahman Z, Bekkers RLM, van der Burg SH, Trutnovsky G, van Esch EMG. Muntinga CLP, et al. Among authors: van esch emg. J Immunother Cancer. 2025 Oct 20;13(10):e012666. doi: 10.1136/jitc-2025-012666. J Immunother Cancer. 2025. PMID: 41120128 Free PMC article. Clinical Trial.
Improving imiquimod use in cervical high-grade squamous intraepithelial lesions: A qualitative study.
Muntinga CLP, Schellekens HCJ, Penders CGJ, van Meir H, Nieuwenhuyzen-De Boer GM, van de Sande AJM, van Beekhuizen HJ, de Vos Van Steenwijk PJ, Bekkers RLM, van Esch EMG. Muntinga CLP, et al. Among authors: van esch emg. Acta Obstet Gynecol Scand. 2025 Sep;104(9):1712-1719. doi: 10.1111/aogs.70004. Epub 2025 Jul 9. Acta Obstet Gynecol Scand. 2025. PMID: 40632662 Free PMC article.
Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial.
van de Sande AJM, van Baars R, Koeneman MM, Gerestein CG, Kruse AJ, van Esch EMG, de Vos van Steenwijk PJ, Muntinga CLP, Willemsen SP, van Doorn HC, van Kemenade FJ, van Beekhuizen HJ. van de Sande AJM, et al. Among authors: van esch emg. BJOG. 2025 Jul;132(8):1056-1064. doi: 10.1111/1471-0528.17808. Epub 2024 Mar 31. BJOG. 2025. PMID: 38556619 Free PMC article. Clinical Trial.
28 results